Therapeutic drug concentrations of teicoplanin in clinical settings. - Wikidata - awgldk - TriplyDB

Therapeutic drug concentrations of teicoplanin in clinical settings.

Therapeutic drug concentrations of teicoplanin in clinical settings.

http://www.wikidata.org/entity/Q37673498

about

Is therapeutic drug monitoring of teicoplanin useful?

P2860

Q37673485-B6645AF6-03D1-4C1C-8E30-F0C23F71B746

P2860

Therapeutic drug concentrations of teicoplanin in clinical settings.

http://www.wikidata.org/entity/Q37673498

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic drug concentrations of teicoplanin in clinical settings.

@en

Therapeutic drug concentrations of teicoplanin in clinical settings.

@nl

type

label

Therapeutic drug concentrations of teicoplanin in clinical settings.

@en

Therapeutic drug concentrations of teicoplanin in clinical settings.

@nl

prefLabel

Therapeutic drug concentrations of teicoplanin in clinical settings.

@en

Therapeutic drug concentrations of teicoplanin in clinical settings.

@nl

P1433

Q37673498-DD2B774A-E6F4-4462-BC06-DDFDD9D2597E

P1476

Q37673498-BA59B77A-41ED-4AB1-8727-17163442811E

P2093

Q37673498-0EE3DDE0-D78D-43E3-8B5A-D1B77377B873

Q37673498-1684E79A-C9DE-4DAD-9F0A-339C0109F8C4

Q37673498-2D46310E-9B9E-4454-AB7E-0F2C4E610A7A

Q37673498-4A9D0D19-4E98-4C43-BE19-21DDBD1E58E5

Q37673498-582C1748-799E-483E-91DC-4EB20C2BB08A

Q37673498-5BB29C71-E373-4004-97BD-AD96C04C8AFF

Q37673498-78174CB4-4D7A-4DD1-AD90-8B96B2B8CAEC

Q37673498-99CE1CA9-1488-46D7-A04D-3CC880AA623A

Q37673498-D050E006-AF14-48CA-9072-E3A49277C4B8

P2860

Q37673498-0F1E487B-3847-401B-85A5-6BCCAC8AC497

Q37673498-2A859E33-2803-4125-B66E-97B9F85D99CC

Q37673498-3BD580A9-F461-4CF6-BAEE-04E667ADF1B2

Q37673498-4113C1D8-1779-44C4-B02B-67AE93466073

Q37673498-423C9C58-E6C4-476C-8A70-8F05FE3F6D65

Q37673498-58853053-14BF-4B62-9E7C-DB30533058B5

Q37673498-6C4FE5E5-3951-483C-B12B-2EF5E4C504BF

Q37673498-73669C56-5A01-49B9-8E28-AF6F160D48E6

Q37673498-CE82BABB-EBFF-4D71-A8B1-0869B6F4C9AC

Q37673498-DED7A67A-BE50-428F-863B-1336CA5BA94A

P304

Q37673498-CB3140CF-A3F3-4C57-9F93-680BE9337BDC

P31

Q37673498-7C60973F-4936-422F-8F53-95F38005331B

P356

Q37673498-7A5541CB-2DC5-42AD-A18F-6395B2547C10

P433

Q37673498-08D9D04F-9649-4E00-8855-326C09C0D8EF

P478

Q37673498-CBB92299-52A5-458E-A795-29EA430E6CED

P577

Q37673498-885A5A78-0921-4616-BA26-D1DE2BA0D096

P5875

Q37673498-3A583CF3-F2C7-4637-AAB7-F913200422E6

P698

Q37673498-1273BE31-3655-4DCC-91FB-31F5560EC369

P932

Q37673498-29CAB1D6-BC01-405D-A0D3-C1A2A6FF470E

P356

IC.2014.46.1.35

P1433

Infection & chemotherapy

P1476

Therapeutic drug concentrations of teicoplanin in clinical settings.

@en

P2093

Cheol-Woo Kim

http://www.w3.org/2001/XMLSchema#string

Hye-Kyung Lee

http://www.w3.org/2001/XMLSchema#string

Jae Hyoung Im

http://www.w3.org/2001/XMLSchema#string

Ji-Hyeon Baek

http://www.w3.org/2001/XMLSchema#string

Jin Yeob Yeo

http://www.w3.org/2001/XMLSchema#string

Jin-Soo Lee

http://www.w3.org/2001/XMLSchema#string

Moon-Hyun Chung

http://www.w3.org/2001/XMLSchema#string

Moon-Seok Nam

http://www.w3.org/2001/XMLSchema#string

So-Yun Nah

http://www.w3.org/2001/XMLSchema#string

P2860

Teicoplanin versus vancomycin for proven or suspected infection

Clinical pharmacokinetics of teicoplanin.

Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses

Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin

Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.

Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis.

Dosage recommendations for teicoplanin.

Analyses of teicoplanin concentrations from 1994 to 2006 from a UK assay service.

Significance of individual adjustment of initial loading dosage of teicoplanin based on population pharmacokinetics.

Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.

P304

35-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3947/IC.2014.46.1.35

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261295661

http://www.w3.org/2001/XMLSchema#string

P698

24693468

http://www.w3.org/2001/XMLSchema#string

P932

3970309

http://www.w3.org/2001/XMLSchema#string